Clover Health Investments, Corp. /De
CLOV· Finance· Fiscal year ends in December
CEO pay in FY2025Stock -25.4% in FY2025
Jamie L. Reynoso is the CEO of Clover Health Investments, Corp. /De and was paid $1.5M in FY2025 (Dec), down 69%.
Pay$100 in the stock at the end of FY20 → $3
Executives5
See all- 1Peter KuipersChief Financial OfficerFY2025
- 2Jamie L. ReynosoChief Executive Officer of Medicare AdvantageFY2025
- 3Andrew ToyCo-Founder and Chief Executive OfficerFY2025
- 4Conrad WaiChief Executive Officer of Counterpart HealthFY2025
- 5Brady PriestChief Executive Officer of Clover Care ServicesFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allClover Health Investments, Corp. /De paid its 5 named executives $7.2M in total in FY2025 (Dec). CEO Andrew Toy was paid $1.3M of that.
| Name | |||
|---|---|---|---|
| Peter KuipersChief Financial Officer | Not disclosed | ||
| Jamie L. ReynosoChief Executive Officer of Medicare Advantage | |||
| Andrew ToyCo-Founder and Chief Executive Officer | |||
| Conrad WaiChief Executive Officer of Counterpart Health | Not disclosed | ||
| Brady PriestChief Executive Officer of Clover Care Services |
of each named executive, from the Summary Compensation Table of each proxy.
Peers19
See all%20--%3e%3cdefs%3e%3cstyle%3e%20.st0%20{%20fill:%20%23fff;%20}%20%3c/style%3e%3c/defs%3e%3cg%20id='Layer_2'%3e%3cg%20id='Layer_1-2'%3e%3cpath%20class='st0'%20d='M41.2,129.5c-4-2-7.6-4.9-10.5-8.4-3.1-3.7-5.5-7.9-7.1-12.4-1.8-4.9-2.7-10-2.7-15.2,0-32,26.7-49.4,23.8-81.8,0-1.8-.3-3.6-.9-5.3-.5-1.6-1.4-3.1-2.5-4.3,4,2,7.6,4.9,10.5,8.4,3.1,3.7,5.5,7.9,7.1,12.4,1.7,4.9,2.6,10,2.7,15.2,0,27.7-25.3,48-25.3,77.7,0,2.6.4,5.2,1.3,7.6.9,2.2,2.2,4.2,3.6,6.1'/%3e%3cpath%20class='st0'%20d='M65.2,127.7c-2.7-1.4-5.1-3.3-7.1-5.6-2.1-2.5-3.7-5.3-4.8-8.4-1.2-3.3-1.8-6.7-1.8-10.2,0-21.5,19.7-33.7,16.6-61.4,3.8,3.4,7,9.5,8.8,14,1.2,3.3,1.8,6.7,1.8,10.2,0,18.5-16.9,32.1-16.9,52.1,0,1.7.3,3.5.9,5.1.5,1.6,1.4,3,2.5,4.2'/%3e%3cpath%20class='st0'%20d='M15.8,91.2c-2.7-1.4-5.1-3.3-7.1-5.6-2.1-2.5-3.7-5.3-4.8-8.4-1.2-3.3-1.8-6.7-1.8-10.2,0-21.5,19.7-33.7,16.6-61.4,3.8,3.4,7,9.5,8.8,14,1.2,3.3,1.8,6.7,1.8,10.2,0,18.5-16.9,32.1-16.9,52.1,0,1.7.3,3.5.9,5.1.5,1.6,1.4,3,2.5,4.2'/%3e%3cpath%20class='st0'%20d='M68.6,9.4c0,1.9-1.5,3.5-3.4,3.6s-3.5-1.5-3.6-3.4,1.5-3.5,3.4-3.6c0,0,0,0,0,0,1.9,0,3.4,1.4,3.5,3.3,0,0,0,0,0,0ZM62.5,9.4c0,1.4,1.1,2.7,2.5,2.7,0,0,0,0,0,0,1.4,0,2.6-1.1,2.6-2.6,0,0,0,0,0-.1,0-1.4-1.2-2.6-2.6-2.6s-2.6,1.2-2.6,2.6h0ZM64.6,11.2h-.8v-3.4c.4,0,.9-.1,1.3,0,.4,0,.8,0,1.2.2.2.2.3.5.3.7,0,.4-.3.7-.7.8h0c.3.1.6.5.6.8,0,.3.1.6.2.9h-.8c-.1-.3-.2-.5-.3-.8,0-.4-.3-.5-.7-.5h-.4v1.4ZM64.6,9.3h.4c.4,0,.8-.1.8-.5s-.2-.5-.7-.5c-.1,0-.3,0-.4,0v1Z'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board4
See all- Demetrios L. KouzoukasLead independent director · 3 yr on the boardIndependentCo-Founder, Chief Executive Officer and Director—Paid as an executive
- Lee A. ShapiroDirector · 3 yr on the boardIndependentCo-Founder, Chief Executive Officer and Director—Paid as an executive
- William G. Robinson, Jr.Director · 3 yr on the boardIndependentCo-Founder, Chief Executive Officer and Director—Paid as an executive
- Anna U. LoengardDirector · 2 yr on the boardIndependentCo-Founder, Chief Executive Officer and Director—Paid as an executive
The board of the latest proxy (FY2024).
Activity
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayClover Health Investments, Corp. /De CEO pay rose 92% to $4.8M. The stock rose 231% in FY2024 (Dec).DEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayClover Health Investments, Corp. /De CEO pay fell 93% to $10.2M. The stock fell 75% in FY2022 (Dec).DEF 14A
Filings6
See all| Proxy statement | DEF 14A | Apr 28, 2026 | FY2025 |
| Annual report | 10-K | Feb 27, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 28, 2025 | FY2024 |
| Annual report | 10-K | Mar 3, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Mar 14, 2024 | FY2023 |
